|
Net income
|
|
$38.5m
|
$12.7m
|
$5.8m
|
$38.6m
|
$36.1m
|
$44.1m
|
|
Depreciation and amortization
|
|
$14.7m
|
$13.7m
|
$15.7m
|
$15.7m
|
$16.4m
|
$18.6m
|
|
Amortization of original issue discount and debt issue costs
|
|
$2.2m
|
$3.2m
|
$740k
|
$479k
|
$1.1m
|
$1.3m
|
|
Amortization of inventory step-up
|
|
—
|
—
|
$4.3m
|
—
|
$3.9m
|
$1.3m
|
|
Deferred income taxes
|
|
($12.2m)
|
$4.8m
|
($1.1m)
|
($210k)
|
($2.1m)
|
$2.4m
|
|
Stock-based compensation
|
|
—
|
$355k
|
$31.9m
|
$9.4m
|
$8.4m
|
$12.2m
|
|
Remeasurement of contingent consideration
|
|
—
|
—
|
—
|
—
|
$1.2m
|
$1.9m
|
|
(Recoveries from) provision for losses on accounts receivable
|
|
$177k
|
($188k)
|
$417k
|
$66k
|
$764k
|
($108k)
|
|
Unrealized foreign exchange transaction gain
|
|
($940k)
|
$102k
|
$1.5m
|
($602k)
|
$1.9m
|
($2.4m)
|
|
Other loss (gain)
|
|
—
|
—
|
($170k)
|
($381k)
|
$496k
|
$390k
|
|
Accounts receivable
|
|
$11.8m
|
($4.6m)
|
($11.5m)
|
$6.6m
|
($24.9m)
|
$8.4m
|
|
Inventories
|
|
$1.6m
|
($3.2m)
|
$1.2m
|
($10.2m)
|
$10.0m
|
($3.6m)
|
|
Prepaid expenses and other assets
|
|
$1.8m
|
($4.6m)
|
($7.7m)
|
($302k)
|
($5.9m)
|
($4.5m)
|
|
Accounts payable and other liabilities
|
|
$2.1m
|
$2.7m
|
$5.5m
|
$14.0m
|
($15.6m)
|
($16.4m)
|
|
Purchase of property and equipment
|
|
($4.7m)
|
($2.8m)
|
($4.5m)
|
($6.7m)
|
($5.7m)
|
($6.9m)
|
|
Proceeds from disposition of property and equipment
|
|
$12.4m
|
—
|
$411k
|
$207k
|
$55k
|
$77k
|
|
Proceeds from revolving credit facilities
|
|
$382.1m
|
$258.0m
|
$43.0m
|
—
|
$5.5m
|
—
|
|
Principal payments on revolving credit facilities
|
|
($384.2m)
|
($258.6m)
|
($43.0m)
|
—
|
($5.5m)
|
—
|
|
Proceeds from term loans
|
|
$219.6m
|
$198.7m
|
—
|
—
|
$129.4m
|
$97.5m
|
|
Principal payments on term loans
|
|
($276.4m)
|
($266.0m)
|
($10.1m)
|
($10.0m)
|
($43.3m)
|
($13.8m)
|
|
Proceeds from insurance premium financing
|
|
$2.7m
|
$5.0m
|
$4.0m
|
$3.9m
|
—
|
—
|
|
Principal payments on insurance premium financing
|
|
($2.9m)
|
($3.1m)
|
($5.0m)
|
($4.0m)
|
($2.2m)
|
—
|
|
Proceeds from exercise of stock options
|
|
—
|
—
|
—
|
—
|
—
|
$3.4m
|
|
Proceeds from secondary offering, net of underwriter discounts
|
|
—
|
—
|
$56.3m
|
—
|
$91.8m
|
—
|
|
Deferred offering costs
|
|
—
|
($4.8m)
|
($3.0m)
|
—
|
($683k)
|
—
|
|
Other
|
|
—
|
($43k)
|
($25k)
|
$33k
|
$37k
|
$207k
|
|
Accruals and accounts payable for capital expenditures
|
|
—
|
$197k
|
$172k
|
$234k
|
$176k
|
$139k
|
|
Net cash provided by operating activities
|
|
$45.4m
|
$40.1m
|
$46.4m
|
$73.2m
|
$31.8m
|
$63.7m
|
|
Business acquisitions, net of cash acquired
|
|
—
|
—
|
($55.5m)
|
—
|
($141.8m)
|
($89.6m)
|
|
Net cash used in investing activities
|
|
$19.8m
|
($2.8m)
|
($59.6m)
|
($6.5m)
|
($147.4m)
|
($96.4m)
|
|
Payments for debt issuance costs
|
|
—
|
($2.2m)
|
—
|
—
|
($3.1m)
|
—
|
|
Dividends distributed
|
|
—
|
($12.8m)
|
($11.5m)
|
($12.0m)
|
($13.9m)
|
($15.4m)
|
|
Net cash provided by (used in) financing activities
|
|
($64.9m)
|
($6.6m)
|
$24.5m
|
($24.7m)
|
$152.7m
|
$31.6m
|
|
Effect of foreign exchange rates on cash, cash equivalents and restricted cash
|
|
$52k
|
$318k
|
$183k
|
$438k
|
$224k
|
$1.5m
|
|
Change in cash, cash equivalents and restricted cash
|
|
$353k
|
$31.0m
|
$11.4m
|
$42.4m
|
$37.2m
|
$394k
|
|
Cash, cash equivalents and restricted cash, beginning of period
|
|
$2.9m
|
$33.9m
|
$45.3m
|
$87.7m
|
$124.9m
|
$125.3m
|
|
Cash paid for interest
|
|
—
|
$13.3m
|
$6.1m
|
$10.1m
|
$14.4m
|
$17.8m
|
|
Taxes paid in connection with employee stock transactions
|
|
—
|
$1.2m
|
($6.3m)
|
($2.7m)
|
($5.3m)
|
($40.2m)
|
|
Cash paid for income taxes, net
|
|
—
|
$1.2m
|
$1.4m
|
$8.7m
|
$24.2m
|
$24.9m
|